Actuate Therapeutics Inc. Common stock (ACTU) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Actuate Therapeutics Inc. Common stock, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$0.38
−4.06% today
Market cap
$10M
Overall quality
64/100
Kronos AI 30-day
—
Actuate Therapeutics Inc. Common stock (ACTU) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $10M. It trades at $0.38, down 4.06% today. Its overall quality score is 64 out of 100, ranked against the whole US market. 2 analysts' average target of $10.50 implies +2663.2% from today's price.
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.50 |
| Low – high | $6.00 – $15.00 |
| Analysts | 2 |
| Upside to average | +2663.2% |
Kronos AI 30-day forecast
No forecast for this listing.
Quality scores
| Profitability | 50 |
| Solvency | 90 |
| Growth | 53 |
| Overall | 64 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.